CaffShock® is a botanical phytocomplex of 5 plants: green coffee, guaranà, green tea, maca and maté. CaffShock® is naturally rich in caffeine, chlorogenic acid and polyphenols. Recent studies show that caffeine improves several brain functions, including memory, mood, alertness, energy levels and general mental function; chlorogenic acid and polyphenols have anxiolytic effects and antioxidant activity.
The vegetable matrices used in CaffShock® are recognized and admitted by the Ministry of Health (Annex 1-Botanicals of the DM 10 August 2018), with approved health claims for tonic-adaptogenic activity, metabolic support, antioxidant activity, drainage of liquids, intestinal function, balance of body weight, stimulation of lipid metabolism.
CaffShock® is a “Made in Italy” product and thanks to its solubility, it is easy to add to the composition of preparations such as sachets, capsules, tablets, hot and cold drinks, tea, instant drinks, yoghurt, ice cream, snacks. CaffShock® is a plant phytocomplex indicated in formulations of nutraceutical or functional products for overweight subjects or subjects with metabolic diseases, to reduce the accumulation of fat in adipose tissue and to favor a thermogenic action.
CaffShock® is indicated for:
The results of in vitro studies conducted on the product show the ability of CaffShock® to reduce the accumulation of triglycerides in pre-adipocyte cells, even in the presence of an excessive caloric intake with the meal. This effect favors the “reprogramming” of the adipocytes making them able to partially dissipate the absorbed fats in heat, with a consequent decrease in absorbed fat and accumulation of triglycerides. In fact, a high accumulation of triglycerides, in addition to increasing fat mass, increases the risk of developing atherosclerosis, cardiovascular disease and diabetes. CaffShock® also proves to have a thermogenic effect, useful in reducing body fat mass with a consequent “slimming” effect.
It is important to act on inflammation especially when it comes to conditions that predispose the onset and development of Metabolic Syndrome or diabetes, obesity and respiratory or cardiovascular diseases. Preclinical studies have demonstrated the efficacy of CaffShock® in significantly inhibiting the release of pro-inflammatory cytokines (in particular, IL6).